AL-15469A [moxifloxacin] for the treatment of bacterial conjunctivitis.
Phase of Trial: Phase III
Latest Information Update: 02 Mar 2012
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections; Infectious conjunctivitis
- Focus Therapeutic Use
- Sponsors Alcon
- 02 Mar 2012 Actual end date (1 Dec 2006) added as reported by ClinicalTrials.gov.
- 06 Oct 2006 New trial record.